Analyst Ratings for Cohen & Steers Inc. (CNS)Updated: 2017-07-27
Shares of Cohen & Steers Inc. (NYSE:CNS) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for CNS last month.
3 analysts declared CNS a buy, 0 gave an overweight rating, 3 gave a hold rating, 1 issued an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
A number of analysts gave price targets for CNS. The maximum price target given was 46, implying potential capital gains of 10.84 percent. The lowest price target was 35, implying potential capital losses of -15.66 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 4.04 percent. The average change in earnings estimates over the last 90 days is 4.04 percent. Meanwhile, fiscal year estimates have been revised upwards by 2.82 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 2.82 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 3 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.
CNS has an estimated earnings growth rate of -3.87 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. CNS has a PEG ratio of -5.2.
CNS has traded between a high of 43.54 and a low of 33.16 over the past year. The current market price is above the trailing year's low by 25.15 percent, and 4.69 percent below the high. CNS has a price/earnings ratio of 20.13. Investors typically compare the P/E ratio to a company's peers in the industry. The CNS value stock report compares CNS to some of its peers using value stock charts. The market cap of CNS is $1.94 billion. CNS is estimated to release their earnings results for the quarter on 0000-00-00, days from today.